Compound ID | 2926
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against methicillin-resistant Staphylococcus aureus; disrupts integrity of cell membrane (membrane-active agent) when in combination with ampicillin or amoxicillin |
| Description: | Synthetic compound; weakly inhibits MRSA on its own (220-240 uM); potentiates amoxicillin and ampicillin (reduces MIC to 8.8 fold); low haemolytic activity (16% lysis at 100 uM) and mammalian cytotoxicity; prevents formation of biofilm and disrupts established biofilm; shows better therapeutic outcome of MRSA infection in rats compared to vancomycin when administered in combination with amoxicillin and ampicillin |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://pubs.acs.org/doi/10.1021/acsinfecdis.3c00696 |